Advertisement

Idiopathic Pulmonary Fibrosis

Advances in Diagnostic Tools and Disease Management

  • Hiroyuki Nakamura
  • Kazutetsu Aoshiba

Table of contents

  1. Front Matter
    Pages i-x
  2. Definition, Epidemiology, and Pathogenesis

    1. Front Matter
      Pages 1-1
    2. Shinji Abe, Akihiko Gemma
      Pages 3-9
    3. Kazuyoshi Kuwano, Jun Araya, Hiromichi Hara
      Pages 11-25
    4. Yoshiki Ishii
      Pages 27-42
    5. Yasuhiko Nishioka
      Pages 43-58
  3. Diagnosis

    1. Front Matter
      Pages 59-59
    2. Hirofumi Chiba, Hiroki Takahashi
      Pages 61-76
    3. Yoshinori Kawabata
      Pages 105-132
    4. Hidehiro Watanabe
      Pages 133-144
  4. Management and Prognosis

    1. Front Matter
      Pages 145-145
    2. Tomohiro Handa, Arata Azuma
      Pages 147-159
    3. Yukihiro Umeda, Tamotsu Ishizuka, Takeshi Ishizaki
      Pages 171-188
  5. Topics

    1. Front Matter
      Pages 203-203
    2. Yoshiteru Morio, Kazuhisa Takahashi
      Pages 205-215
    3. Nobuyuki Koyama
      Pages 217-247

About this book

Introduction

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

Keywords

HRCT IIP IPF KL-6 SP-A SP-D

Editors and affiliations

  • Hiroyuki Nakamura
    • 1
  • Kazutetsu Aoshiba
    • 2
  1. 1.Department of Respiratory MedicineTokyo Medical University, Ibaraki Medical Center IbarakiJapan
  2. 2.Department of Respiratory Medicine Tokyo Medical University, Ibaraki Medical CenterIbarakiJapan

Bibliographic information

  • DOI https://doi.org/10.1007/978-4-431-55582-7
  • Copyright Information Springer Japan 2016
  • Publisher Name Springer, Tokyo
  • eBook Packages Medicine
  • Print ISBN 978-4-431-55581-0
  • Online ISBN 978-4-431-55582-7
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology
Internal Medicine & Dermatology